Inventor · disambiguated record
Douglas S. Conklin
Also filed as: CONKLIN DOUGLAS · CONKLIN DOUGLAS S
11 granted patents·8 pending applications·235 citations·filing 1997–2023
90Inventor score
Files withUNIV NEW YORK STATE RES FOUND11HANNON GREGORY J3COLD SPRING HARBOR LAB2CONKLIN DOUGLAS S1GENETICA INC1
Top patents by PatentIndex Score
19 records- 0193US8383599B2Methods and compositions for RNA interferenceCOLD SPRING HARBOR LAB·Filed 2008·Granted Feb 26, 2013·24 cites·20 claims
- 0293US6255071B1Mammalian viral vectors and their usesCOLD SPRING HARBOR LAB·Filed 1997·Granted Jul 3, 2001·156 cites·58 claims
- 0390US8202846B2Methods and compositions for RNA interferenceHANNON GREGORY J·Filed 2004·Granted Jun 19, 2012·33 cites·10 claims
- 0488US8829264B2Methods and compositions for RNA interferenceHANNON GREGORY J·Filed 2012·Granted Sep 9, 2014·7 cites·10 claims
- 0584US8153776B2Methods and compositions for RNA interferenceHANNON GREGORY J·Filed 2007·Granted Apr 10, 2012·5 cites·10 claims
- 0683US8513212B2Bruton's tyrosine kinase as anti-cancer drug targetCONKLIN DOUGLAS S·Filed 2011·Granted Aug 20, 2013·7 cites·12 claims
- 0776US2022213219A1Bruton's Tyrosine Kinase as Anti-Cancer Drug TargetUNIV NEW YORK STATE RES FOUND·Filed 2021·Application pending·0 cites
- 0874US9095592B2Bruton's tyrosine kinase as anti-cancer drug targetUNIV NEW YORK STATE RES FOUND·Filed 2013·Granted Aug 4, 2015·2 cites·22 claims
- 0971US9637554B2Bruton's tyrosine kinase as anti-cancer drug targetUNIV NEW YORK STATE RES FOUND·Filed 2015·Granted May 2, 2017·1 cites·5 claims
- 1066US11149092B2Bruton's tyrosine kinase as anti-cancer drug targetUNIV NEW YORK STATE RES FOUND·Filed 2017·Granted Oct 19, 2021·0 cites·14 claims
- 1164US2025320501A1Palmitoylation of the alternative amino terminus of the btk-c isoform controls subcellular distribution and signalingUNIV NEW YORK STATE RES FOUND·Filed 2023·Application pending·0 cites
- 1261US2014288098A1Bruton's Tyrosine Kinase As Anti-Cancer Drug TargetUNIV NEW YORK STATE RES FOUND·Filed 2014·Application pending·0 cites
- 1358US10421820B2Bruton's tyrosine kinase as anti-cancer drug targetUNIV NEW YORK STATE RES FOUND·Filed 2016·Granted Sep 24, 2019·0 cites·13 claims
- 1458US2004086884A1Methods and compositions for RNA interferenceGENETICA INC·Filed 2003·Application pending·0 cites
- 1557US2010261776A1Bruton's tyrosine kinase as anti-cancer drug targetUNIV NEW YORK STATE RES FOUND·Filed 2009·Application pending·0 cites
- 1655US10668068B2Treating cancer with drug combinationsUNIV NEW YORK STATE RES FOUND·Filed 2015·Granted Jun 2, 2020·0 cites·7 claims
- 1755US2020289513A1Treating Cancer with Drug CombinationsTHE RES FOUNDATION FOR SUNY·Filed 2020·Application pending·0 cites
- 1851US2016206646A1Bruton's Tyrosine Kinase as Anti-Cancer Drug TargetUNIV NEW YORK STATE RES FOUND·Filed 2014·Application pending·0 cites
- 1949US2010267803A1Regulators Of Fat Metabolism As Anti-Cancer TargetsUNIV NEW YORK STATE RES FOUND·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Douglas S. Conklin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →